What Does One Do About Those Pesky VUSs? Ambry’s Translational Genomics Lab brings new understanding to Variants of Uncertain Significance (VUS)

• This webinar will provide an overview of Ambry’s Translational Genomics Lab (ATG) services and how it can bring new understanding to VUSs and help you better manage your patients.  The ATG lab tests for various types of alterations that are often difficult to assess with the limited information available. We offer specialized studies providing the necessary data points to better define whether a VUS is benign or pathogenic. During this webinar Dr. Karam will describe an RNA protocol for the assessment of splicing variants and compare the protocol to other assays.  He will also illustrate how this protocol has been used to analyze splicing variants at Ambry to improve the diagnostic yield. We hope that with this information we can bring clarity to an uncertain result and, ultimately, find the answer so that you can better guide patient treatment.

  Who should attend:

  Genetic Counselors, Geneticists, others interested in bringing clarity to VUSs

   

  Please note: You must attend the full length of the live course and complete the evaluation in order to claim CEUs.

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Laura Panos Smith | Moderator

Director, Genetic Specialists

Mrs. Smith graduated from University of North Carolina at Chapel Hill with a B.S. in Biology. As an undergraduate, she worked in a lab studying dental genetics. She then received a M.S. in Genetic Counseling from The University of Texas Health Science Center in Houston/ MD Anderson. Prior to joining Ambry, Mrs. Smith worked for the Baylor Health Care System developing the cancer and cardiovascular genetic counseling clinics. She is currently the Licensure Chair for the Texas Society of Genetic Counselors and the Vice-Chair of the National Society of Genetic Counselors’ Access and Service Delivery Committee. At Ambry, Mrs. Smith is the director of the field based genetic specialist team.